ReviewBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2022

RdRp inhibitors and COVID-19: Is molnupiravir a good option?

Seyed Mohammad Reza Hashemian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.